Cargando…

Harnessing type I interferon-mediated immunity to target malignant brain tumors

Type I interferons have long been appreciated as a cytokine family that regulates antiviral immunity. Recently, their role in eliciting antitumor immune responses has gained increasing attention. Within the immunosuppressive tumor microenvironment (TME), interferons stimulate tumor-infiltrating lymp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Juhee, Kang, In, La, Jeongwoo, Ku, Keun Bon, Kang, Byeong Hoon, Kim, Yumin, Park, Won Hyung, Lee, Heung Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247981/ https://www.ncbi.nlm.nih.gov/pubmed/37304294 http://dx.doi.org/10.3389/fimmu.2023.1203929

Ejemplares similares

γδ T cells as a potential therapeutic agent for glioblastoma
por: Kang, In, et al.
Publicado: (2023)

Regulation of c-SMAC formation and AKT-mTOR signaling by the TSG101-IFT20 axis in CD4(+) T cells
por: Jeong, Jiung, et al.
Publicado: (2023)

A Microbiota-Dependent Subset of Skin Macrophages Protects Against Cutaneous Bacterial Infection
por: Park, Young Joon, et al.
Publicado: (2022)

Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2
por: Jung, Hi Eun, et al.
Publicado: (2023)

γδ T Cells in Brain Homeostasis and Diseases
por: Park, Jang Hyun, et al.
Publicado: (2022)

The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection
por: Wang, Bowen, et al.
Publicado: (2017)

The immune landscape of high-grade brain tumor after treatment with immune checkpoint blockade
por: Park, Jang Hyun, et al.
Publicado: (2022)

Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis
por: La Manna, Marco P., et al.
Publicado: (2020)

Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients
por: van Nieuwland, Marieke, et al.
Publicado: (2023)

Type I Interferon in Human Autoimmunity
por: Niewold, Timothy B.
Publicado: (2014)

Breaking down the cellular responses to type I interferon neurotoxicity in the brain
por: Viengkhou, Barney, et al.
Publicado: (2023)

A Novel Type-I Interferon Family, Bovine Interferon-Chi, Is Involved in Positive-Feedback Regulation of Interferon Production
por: Guo, Yongli, et al.
Publicado: (2020)

Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production
por: Lee, Amanda J., et al.
Publicado: (2019)

Interaction Between Non-Coding RNAs and Interferons: With an Especial Focus on Type I Interferons
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Type I Interferons as Regulators of Lung Inflammation
por: Makris, Spyridon, et al.
Publicado: (2017)

Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors
por: Kang, Byeong Hoon, et al.
Publicado: (2022)

Harnessing NK Cells for Cancer Treatment
por: Minetto, Paola, et al.
Publicado: (2019)

The Role of Optineurin in Antiviral Type I Interferon Production
por: Outlioua, Ahmed, et al.
Publicado: (2018)

Type I Interferons, Autophagy and Host Metabolism in Leprosy
por: Toledo Pinto, Thiago Gomes, et al.
Publicado: (2018)

The Dual Nature of Type I and Type II Interferons
por: Lee, Amanda J., et al.
Publicado: (2018)

The Protective Role of Type I Interferons in the Gastrointestinal Tract
por: Kotredes, Kevin P., et al.
Publicado: (2017)

Insights Into Type I and III Interferons in Asthma and Exacerbations
por: Rich, Helen E., et al.
Publicado: (2020)

Kallikrein–Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation
por: Seliga, Alecia, et al.
Publicado: (2018)

Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy
por: Chen, Siqi, et al.
Publicado: (2021)

Type I Interferons in Bacterial Infections: A Balancing Act
por: Kovarik, Pavel, et al.
Publicado: (2016)

Fine-Tuning of Type I Interferon Response by STAT3
por: Tsai, Ming-Hsun, et al.
Publicado: (2019)

Type I Interferons and Natural Killer Cell Regulation in Cancer
por: Müller, Lena, et al.
Publicado: (2017)

Role of Type I and II Interferons in Colorectal Cancer and Melanoma
por: Di Franco, Simone, et al.
Publicado: (2017)

The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
por: Schreiber, Gideon
Publicado: (2020)

Type I Interferon Induction in Cutaneous DNA Damage Syndromes
por: Klein, Benjamin, et al.
Publicado: (2021)

Harnessing the Immunomodulatory Properties of Bacterial Ghosts to Boost the Anti-mycobacterial Protective Immunity
por: Lim, Jieling, et al.
Publicado: (2019)

Harnessing Apoptotic Cell Clearance to Treat Autoimmune Arthritis
por: Saas, Philippe, et al.
Publicado: (2017)

Editorial: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance
por: Boscardin, Silvia Beatriz, et al.
Publicado: (2020)

Chronovaccination: Harnessing circadian rhythms to optimize immunisation strategies
por: Otasowie, Claire O., et al.
Publicado: (2022)

Harnessing the small intestinal axis to resolve systemic inflammation
por: Bodmer, Mark, et al.
Publicado: (2022)

Traumatic Brain Injury Induces cGAS Activation and Type I Interferon Signaling in Aged Mice
por: Barrett, James P., et al.
Publicado: (2021)

Hydrogen peroxide attenuates rhinovirus-induced anti-viral interferon secretion in sinonasal epithelial cells
por: Lee, Sang Hag, et al.
Publicado: (2023)

Type I Interferon Regulates the Expression of Long Non-Coding RNAs
por: Carnero, Elena, et al.
Publicado: (2014)

Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences
por: Donovan, Meg L., et al.
Publicado: (2017)

Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons
por: Rabin, Ronald L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tnjgpo6tnogvckof261ag03mbo